Dow Up 0.11% Nasdaq Up 0.50%

Portola Pharmaceuticals, Inc. (PTLA)

-NasdaqGS
27.89 Up 0.80(2.95%) Aug 29, 4:00PM EDT
|After Hours : 27.89 Up 0.00 (0.01%) Aug 29, 4:45PM EDT
Prev Close:27.09
Open:27.13
Bid:27.87 x 1300
Ask:27.89 x 1800
1y Target Est:41.00
Beta:-2.723
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:26.88 - 27.99
52wk Range:19.59 - 31.48
Volume:137,784
Avg Vol (3m):353,598
Market Cap:1.15B
P/E (ttm):N/A
EPS (ttm):-2.93
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PTLA

Comparison

Symbol% ChgMkt Cap
PTLAUp 2.95%1.15B
BAYRYUp 0.95%111.06B
PFEUp 0.03%186.36B
SNY 0.00%143.54B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):116.72
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-3.45
Quarterly EPS Est (Sep-14) :-0.92
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Portola Pharmaceuticals, Inc., a biopharmaceutical company, develops product candidates in the fields of thrombosis and hematology. Its lead compound, Betrixaban, is an oral, once-daily Factor Xa inhibitor in Phase III study for hospital to home p... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback